Our data demonstrated that RIAA inhibited GSK-3β/NF-κB mediated signaling pathways and inflammation, and reduced RA symptoms in CIA mice, suggesting that RIAA may have potential as an anti-inflammatory therapeutic. The gene discussed is NFKB1; the disease is rheumatoid arthritis.